BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 6185599)

  • 1. Immunization with rough mutants of Salmonella minnesota. IV. Protection by antisera to O and rough antigens against endotoxin.
    Johns M; Skehill A; McCabe WR
    J Infect Dis; 1983 Jan; 147(1):57-67. PubMed ID: 6185599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of antisera to J5 and R595 rough mutants to reduce endotoxemic lethality.
    Greisman SE; Johnston CA
    J Infect Dis; 1988 Jan; 157(1):54-64. PubMed ID: 2447200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endotoxin neutralization with rabbit antisera to Escherichia coli J5 and other gram-negative bacteria.
    Warren HS; Novitsky TJ; Bucklin A; Kania SA; Siber GR
    Infect Immun; 1987 Jul; 55(7):1668-73. PubMed ID: 3298063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of polyclonal sera and of monoclonal antibodies active to Salmonella minnesota Re595 lipopolysaccharide during experimental endotoxemia.
    Nys M; Cloes JM; Demonty J; Joassin L
    J Infect Dis; 1990 Nov; 162(5):1087-95. PubMed ID: 1700024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-reactivity of rabbit antibodies to lipopolysaccharides of Escherichia coli J5 and other gram-negative bacteria.
    Siber GR; Kania SA; Warren HS
    J Infect Dis; 1985 Nov; 152(5):954-64. PubMed ID: 2413146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of active and passive immunizations with lipid A and salmonella minnesota Re 595 on gram-negative infections in mice.
    Hodgin LA; Drews J
    Infection; 1976; 4(2):5-10. PubMed ID: 789248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential use of shared antigens for immunization against gram-negative bacillary infections.
    McCabe WR; DeMaria A; Johns M
    Prog Clin Biol Res; 1980; 47():107-17. PubMed ID: 6163155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization with rough mutants of Salmonella minnesota: protective activity of IgM and IgG antibody to the R595 (Re chemotype) mutant.
    McCabe WR; DeMaria A; Berberich H; Johns MA
    J Infect Dis; 1988 Aug; 158(2):291-300. PubMed ID: 3042871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-reactive antigens: their potential for immunization-induced immunity to Gram-negative bacteria.
    McCabe WR; Bruins SC; Craven DE; Johns M
    J Infect Dis; 1977 Aug; 136 Suppl():S161-6. PubMed ID: 330775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralization of Shwartzman-inducing activity by antibodies recognizing the Re core or lipid A structures of lipopolysaccharide from Salmonella minnesota R595 and Pseudomonas vesicularis JCM1477.
    Mashimo J; Mizutani T; Mita A; Kasai N
    Microbiol Immunol; 1991; 35(6):423-34. PubMed ID: 1921759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies to Salmonella lipopolysaccharide: anti-O-polysaccharide antibodies protect C3H mice against challenge with virulent Salmonella typhimurium.
    Colwell DE; Michalek SM; Briles DE; Jirillo E; McGhee JR
    J Immunol; 1984 Aug; 133(2):950-7. PubMed ID: 6203984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-reactive immunoprotective antibodies to Escherichia coli O111 rough mutant J5.
    Sakulramrung R; Domingue GJ
    J Infect Dis; 1985 Jun; 151(6):995-1004. PubMed ID: 3889175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactivity of monoclonal antibody E5 with endotoxin. I. Binding to lipid A and rough lipopolysaccharides.
    Wood DM; Parent JB; Gazzano-Santoro H; Lim E; Pruyne PT; Watkins JM; Spoor ES; Reardan DT; Trown PW; Conlon PJ
    Circ Shock; 1992 Sep; 38(1):55-62. PubMed ID: 1394865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of Salmonella typhimurium Re-LPS antiserum.
    Yu X; Yu Q
    Chin Med Sci J; 1993 Sep; 8(3):151-6. PubMed ID: 8142630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic and immunogenic characteristics of subcellular fractions and whole cells of a rough E. coli 0111 (J5) mutant.
    Sakulramrung R; Domingue GJ
    Immunobiology; 1985 May; 169(4):372-88. PubMed ID: 2408995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of immunity against lethal Haemophilus influenzae type b infection by Escherichia coli core lipopolysaccharide.
    Marks MI; Ziegler EJ; Douglas H; Corbeil LB; Braude AI
    J Clin Invest; 1982 Apr; 69(4):742-9. PubMed ID: 7042755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic homology of endotoxin with a coliform mastitis vaccine strain, Escherichia coli O111:B4 (J5).
    Tyler JW; Spears H; Nelson R
    J Dairy Sci; 1992 Jul; 75(7):1821-5. PubMed ID: 1500577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological relationships between Escherichia coli and Salmonella smooth- and rough-mutant lipopolysaccharides as revealed by enzyme-linked immunosorbent assay for human immunoglobulin G antiendotoxin antibodies.
    Barclay GR; Scott BB
    Infect Immun; 1987 Nov; 55(11):2706-14. PubMed ID: 3312008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization with R mutants of Salmonella minnesota. II. Serological response to lipid A and the lipopolysaccharide of Re mutants.
    Johns MA; Bruins SC; McCabe WR
    Infect Immun; 1977 Jul; 17(1):9-15. PubMed ID: 69613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Protective role of Salmonella R mutants in Salmonella infection in mice (author's transl)].
    Schlecht S; Westphal O
    Zentralbl Bakteriol Orig A; 1979 Oct; 245(1-2):71-88. PubMed ID: 44625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.